Cargo Therapeutics rises 2.2% in trading debut after IPO priced at low end of range

The stock of Cargo Therapeutics, a clinical-stage biotech, rose in its trading debut Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.